Гиполипидемическая терапия у пожилых пациентов. В фокусе — статины и прогноз

Elderly age and dyslipidemia are known high risk factors for cardiovascular morbidity and mortality. The article focuses on the evidence of statin benefits in primary and secondary prevention of cardiovascular complications in very elderly subjects. Importance of the achievement of target lipid levels regardless the age and possibilities of combined lipidlowering therapy in elderly patients are demonstrated. Some aspects of statin safety in elderly subjects are highlighted in the paper.